Ascend Capital’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q1
Sell
-400,000
Closed -$8.39M 216
2013
Q4
$8.39M Buy
+400,000
New +$8.39M 0.26% 105